Selenium suppresses HIV
This article was originally published in The Tan Sheet
Executive Summary
"Daily selenium supplementation can suppress the progression of HIV-1 viral burden and provide indirect improvement" of helper T cell (CD4) count, according to a study published Jan. 22 in the Archives of Internal Medicine. Barry E. Hurwitz, Ph.D., Behavioral Medicine Research Center, University of Miami, Miami, Fla., et al., conducted a randomized, double-blind, placebo controlled trial with 262 patients with HIV. Nutrition 21 provided capsules containing 200 mcg of high-selenium yeast for 141 participants and the remaining 121 took a capsule containing inactive yeast and filler material. "Given the challenges of using conventional pharmacotherapy to achieve and maintain virologic suppression in HIV-spectrum disease, our results support the use of selenium as a simple, inexpensive and safe adjunct therapy," the authors conclude...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.